Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Evoq Remedies Ltd

Your Vote -

Buy

25.00%

Hold

25.00%

Sell

50.00%

25.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Evoq Remedies Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Evoq Remedies has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    15 Oct 2025, 3:50PM As of September 2025, 11.21% is owned by Indian Promoters and 88.79% by Public. <p align=justify> Top two Promoters holding highest number of shares o
  • Evoq Remedies - Integrated Filling (Finance)

    10 Oct 2025, 7:54PM Integrated Filling (Finance)
  • Evoq Remedies - Financial Result For Half Year Ended On 30Th September 2025

    10 Oct 2025, 7:49PM Financial Result fpr half year ended on 30th September 2025
  • Evoq Remedies - Board Meeting Outcome for Outcome Of Board Meeting

    10 Oct 2025, 7:43PM Outcome of Board Meeting hel today i.e. 10th October 2025
  • Evoq Remedies - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    10 Oct 2025, 11:33AM Compliance Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018
  • Evoq Remedies - Board Meeting Intimation for Intimation Of Rescheduling Of Board Meeting

    9 Oct 2025, 1:34PM Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2025 ,inter alia, to consider and ap
  • Evoq Remedies - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 9Th October, 2025

    3 Oct 2025, 3:52PM Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 ,inter alia, to consider and ap
  • Evoq Remedies - Voting Results Of The Annual General Meeting

    19 Sep 2025, 8:00PM Voting Results of the Annual General Meeting held on 17th September, 2025
  • Evoq Remedies - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    19 Sep 2025, 7:57PM Scrutinizer Report of the Annual General Meeting of the Company held on 17th September, 2025.
  • Evoq Remedies - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    19 Sep 2025, 7:57PM Scrutinizer Report of the Annual General Meeting of the Company held on 17th September, 2025.
  • Evoq Remedies - Shareholder Meeting / Postal Ballot-Outcome of AGM

    17 Sep 2025, 6:41PM Outcome and Summary of the Annual General Meeting held today i.e. 17th September, 2025.
  • Evoq Remedies - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    19 Sep 2025, 7:57PM Scrutinizer Report of the Annual General Meeting of the Company held on 17th September, 2025.
  • Evoq Remedies - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    19 Sep 2025, 7:57PM Scrutinizer Report of the Annual General Meeting of the Company held on 17th September, 2025.
  • Evoq Remedies - Intimation Regarding Book Closure

    26 Aug 2025, 4:48PM Intimation of Book Closure
  • Evoq Remedies - Reg. 34 (1) Annual Report.

    26 Aug 2025, 4:42PM Annual Report for the Financial Year 2024-25
  • Evoq Remedies - Intimation Of The Annual General Meeting To Be Held On 17Th September, 2025

    26 Aug 2025, 4:39PM Intimation of the Annual General Meeting to be held on 17th September, 2025
  • Evoq Remedies - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    26 Aug 2025, 4:34PM Outcome of the Board Meeting held on 26th August, 2025
  • Evoq Remedies - Board Meeting Outcome for Outcome Of Board Meeting And Intimation As Per Regulation 30 Of SEBI (LODR) Regulat

    26 Aug 2025, 4:32PM Outcome of the Board Meeting held on 26th August, 2025.
  • Evoq Remedies - Intimation For Withdraw The Proposals For Preferential Issue Of Equity Shares, Which Were Earlier Approved By

    21 Aug 2025, 7:47PM Intimation for Withdrawal of proposed preferential issue.
  • Evoq Remedies - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E., Thursday, 21St August, 2025

    21 Aug 2025, 7:44PM Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Dire

Key fundamentals

Evaluate the intrinsic value of Evoq Remedies Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 44.536 29.476 34.3617 31.3242 0.7426
Liabilities 44.536 29.476 34.3617 31.3242 0.7426
Equity 24.9 13.6 13.6 13.6 0.01
Gross Profit -2.2375 -1.6378 -3.733 1.4629 0.9539
Net Profit 0.0882 0.4524 1.6193 1.0912 0.7138
Cash From Operating Activities -14.623 5.3198 -4.3457 -27.6377 0.031
NPM(%) 0.75 11.16 7.94 6.5 7.12
Revenue 11.7567 4.0525 20.3899 16.7831 10.0248
Expenses 13.9942 5.6903 24.1229 15.3201 9.0709
ROE(%) 0.19 1.01 3.63 2.45 1.6

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Evoq Remedies Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 794.00 0.71 72.26 3.25 301.39 0.63
Lotus Eye Hospital and Institute Ltd 118.90 0.68 377.42 11.85 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 20.80 0.43 0.00 24.61 -39.50 0.00
Astec Lifesciences Ltd 704.00 -4.22 0.00 11.18 -604.77 0.00

Company Info

Our Company was incorporated as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 1956 vide certificate of incorporation issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently the name of our company was changed to "Evoq Remedies Private Limited" on July 15th, 2019 with certificate of Incorporation pursuant to change of name issued by Registrar of Companies, Ahmedabad. Consequent upon the conversion of our Company into public limited company, the name of our Company was changed to "Evoq Remedies Limited" and fresh Certificate of Incorporation dated July 28th, 2021 was issued by Registrar of Companies, Ahmedabad. The Corporate Identification Number of our Company is U24230GJ2010PLC059692.MAJOR EVENTS2010Incorporation of Company as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 19562021Conversion of our Company into public limited company, the name of our Company was changed to "Evoq Remedies Limited" and fresh Certificate of Incorporation dated July 28th, 2021 was issued by Registrar of Companies, Ahmedabad

Our Company was incorporated as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 1956 vide certificate of incorporation issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently the name of our company was changed to "Evoq Remedies Private Limited" on July 15th, 2019 with certificate of Incorporation pursuant to change of name issued by Registrar of Companies, Ahmedabad. Consequent upon the conversion of our Company into public limited company, the name of our Company was changed to "Evoq Remedies Limited" and fresh Certificate of Incorporation dated July 28th, 2021 was issued by Registrar of Companies, Ahmedabad. The Corporate Identification Number of our Company is U24230GJ2010PLC059692.MAJOR EVENTS2010Incorporation of Company as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 19562021Conversion of our Company into public limited company, the name of our Company was changed to "Evoq Remedies Limited" and fresh Certificate of Incorporation dated July 28th, 2021 was issued by Registrar of Companies, Ahmedabad

Read More

Parent Organisation

Evoq Remedies Ltd.

Founded

24/02/2010

Managing Director

Mr.Bhumishth Patel

NSE Symbol

FAQ

The current price of Evoq Remedies Ltd is

The 52-week high for Evoq Remedies Ltd is

The market capitalization of Evoq Remedies Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Evoq Remedies Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Evoq Remedies Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Evoq Remedies Ltd shares.

The CEO of Evoq Remedies Ltd is Mr.Bhumishth Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT